PharmaVentures Ltd.PharmaVentures is a leading results-driven strategic corporate and business development consultancy assisting pharmaceutical and biotechnology companies world-wide.Our professional consultants and analysts have an impressive track record in assisting pharmaceutical and biotechnology organisations world-wide in their corporate and business development activities. Daily contact with the world-wide industry ensures that we have an extensive network of industry contacts and unique in-house information databases. Pharma Ventures can successfully assist you in a number of specific areas. Our specialist services are:
The company has an established track record in assisting companies in successful partnering and, furthermore, has expertise in business development strategies and assessments including clinical and marketing strategy, commercial and business assessments and due diligence, technical and clinical evaluations, portfolio management and market research. The company also assists in negotiation strategies and tactics. For companies wishing to raise finance via private or public offerings PharmaVentures has proven success in writing expert reports.
PharmaVentures has an impressive track record in assisting companies world-wide. |
 |
List of reports from PharmaVentures Ltd.
|
Analysis of Deal Making in Vaccines
11/1/2010 | published by: PharmaVentures Ltd.
... key players from big and small companies doing in this area? How are your potential partners and competitors operating? Around what therapeutic areas are the vaccines deals being done? How does vaccines deal making compare ...
|
more...
|
$4,928.00
|
|
Analysis of Oncology Deals: Trends in Deal Structures and Valuations
12/1/2009 | published by: PharmaVentures Ltd.
... with? What is the impact of the credit crunch in oncology deal making and are the emerging markets having any significant effect on this therapy area? Which technologies are driving the deals and why are ...
|
more...
|
$2,395.00
|
|
Effective Deal Making in Drug Delivery
2/1/2009 | published by: PharmaVentures Ltd.
... to such existing therapeutics is an attractive means of prolonging the commerical viability of marketed drugs. Technologies are more difficult to value than products in clinical development because the technical risks or success rates are ...
|
more...
|
$5,993.00
|
|
Guide to Valuation of Pharmaceutical Licensing Deals
2/1/2009 | published by: PharmaVentures Ltd.
... developments and focuses on the issues of most concern to business development and licensing professionals within the large pharmaceutical, biotechnology and academic network. It fully addresses financial modelling and provides detailed valuation examples. Its content ...
|
more...
|
$2,450.00
|
|
The Royalty Rate Report 2011: A Comprehensive Assessment of Valuation in the Pharmaceutical Sector
6/1/2011 | published by: PharmaVentures Ltd.
... brings you the most up-to-date interpretation of royalty information. It introduces methods for calculating useful fi nancial data missing from the public domain, but essential for deal makers in benchmarking and determining value in your ...
|
more...
|
$8,005.00
|
|
The Royalty Rate Report 2012: A Comprehensive Assessment of Valuation in the Pharmaceutical Sector
3/19/2012 | published by: PharmaVentures Ltd.
... Tiered Royalties, Alternative Structures, Technology Deals, Deal Creativity, Upfront Payments and Milestones, Royalties and IP Values and Market Cap, and Royalty Rates by Phase and Indication. Data and analysis of a recent major survey undertaken ...
|
more...
|
$8,005.00
|
|
Trends in Pharmaceutical Deal Making 2009
6/26/2009 | published by: PharmaVentures Ltd.
... it can be hard to pick the optimum deal type for your situation. Even the most accomplished deal maker is unlikely to have been involved in each and every type of deal. This indispensable report ...
|
more...
|
$2,450.00
|
